Iron sucrose induced morphological and functional changes in the rat kidney

Translational Research

Volumn 148, Issue 5, 2006, Pages 257-262

  Breborowicz, Andrzej ^a   Polubinska, Alicja ^a   Górna, Kinga ^a   Breborowicz, Maciej ^a   Oreopoulos, Dimitrios G ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS FLUID; FERRIC HYDROXIDE SUCROSE; UREA;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT DISORDER; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EXPOSURE; DRUG INFUSION; KIDNEY CLEARANCE; KIDNEY FUNCTION; LONG TERM EXPOSURE; MALE; MORPHOLOGY; NEPHROTOXICITY; NONHUMAN; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; RAT;

EID: 33750282790     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2006.04.008     Document Type: Article

References (20)

1. Kooistra M.P., and Marx J.J.M. The absorption of iron is disturbed in recombinant human erythropoietin-treated peritoneal dialysis patients. Nephrol Dial Transplant 13 (1998) 2578-2582
2. Sengolge G., Horl W.H., and Sunder-Plassman G. Intravenous iron therapy: well tolerated, yet not harmless. Eur J Clin Invest 35 suppl 3 (2005) 46-51
3. Rooyakkers T.M., Stroes E.S., Kooistra M.P., Van Faassen E.E., Hider R.C., Rabelink T.J., et al. Ferric saccharate induces oxygen radicals stress and endothelial dysfunction in vivo. Eur J Clin Invest 32 suppl 1 (2002) 9-16
4. Zager R.A. Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy. Kidney Int 68 (2005) 1533-1542
5. Zager R.A., Johnson A.C.M., and Hanson S.Y. Parenteral iron nephrotoxicity: potential mechanisms and consequences. Kidney Int 66 (2004) 144-156
6. Agarwal R., Vasavada N., Sachs N.G., and Chase S. Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. Kidney Int 65 (2004) 2279-2289
7. Leehey D.J., Palubiak D.J., Chebrolu S., and Agarwal R. Sodium ferric gluconate causes oxidative stress but not acute renal injury in patients with chronic kidney disease: a pilot study. Nephrol Dial Transplant 20 (2005) 135-140
8. Lim C.S., and Vaziri N.D. The effect of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure. Kidney Int 65 (2004) 1802-1809
9. Kadkhodaee M., and Gol A. The role of nitric oxide in iron-induced rat renal injury. Human Exp Toxicol 23 (2004) 533-536
10. Mimic-Oka J., Savic-Radojevic A., Pljesa-Ercegovas M., Opacic M., Simic T., Dimkovic N., et al. Evaluation of oxidative stress after repeated intravenous iron supplementation. Ren Fail 27 (2005) 345-351
11. Koliakos G., Papachristou F., Koussi A., Perifanis V., Tsatra I., Souliou E., et al. Urine biochemical markers of early renal dysfunction are associated with iron overload in β-thalassemia. Clin Lab Haem 25 (2003) 105-109
12. Ebina Y., Okada S., Hamazaki S., Ogino F., Li J.L., and Midorikawa O. Nephrotoxicity and renal cell carcinoma after use of iron-and aluminium-nitrilotriacetate complexes in rats. J Natl Cancer Inst 76 (1986) 107-113
13. Nath K.A., Vercellotti G.M., Grande J.P., Miyoshi H., Paya C.V., Manivel J.C., et al. Heme-induced chronic inflammation: suppresive effect of induced heme oxygenase-1. Kidney Int 59 (2001) 106-117
14. Ishizaka N., Saito K., Noiri E., Sata M., Mori I., Ohno M., et al. Iron dextran causes renal iron deposition but not renal dysfunction in angiotensin-II-treated and untreated rats. Nephron Physiol 98 (2004) 107-113
15. Sanai T., Oochi N., Okada M., Imamura K., Okuda S., and Iida M. Effect of saccharated ferric oxide and iron dextran on the metabolism of phosphorous in rats. J Lab Clin Med 146 (2005) 25-29
16. Chatziantoniou C., and Dussaule J.C. Insights into the mechanisms of renal fibrosis: is it possible to achieve regression?. Am J Physiol 289 (2005) F227-F234
17. Horino T., Ito H., Yamaguchi T., Furihata M., and Hashimoto K. Suppresive effects of iron on TGF-β1 production by renal proximal tubular epithelial cells. Nephron Exp Nephrol 100 (2005) e1-e10
18. Saito K., Ishizaka N., Aizawa T., Sata M., Iso-O N., Noiri E., et al. Role of aberrant iron homeostasis in the upregulation of Transforming Growth Factor-β1 in the kidney of angiotensin II-induced hypertensive rats. Hypertens Res 27 (2004) 599-607
19. Masini A., Ceccarelli D., Giovannini F., Montosi G., Garuti C., and Pietrangelo A. Iron-induced oxidant stress leads to irreversible mitochondrial dysfunction and fibrosis in the liver of chronic iron dosed gerbils. The effect of Silybin. J Bioenerg Biomembr 32 (2000) 175-182
20. Agarwal R. On the nature of proteinuria with acute injury in patients with chronic kidney disease. Am J Physiol 288 (2005) F265-F271